Refocus Group is currently conducting clinical research studies using the PresVIEW™ Scleral Implant (PSI). These studies are designed to determine if implantation of the PSI device in the eye via the Scleral Spacing Procedure (SSP) will:

• Reduce or eliminate the need for reading glasses arising from presbyopia; and/or,
• Reduce intraocular pressure (IOP) to help treat glaucoma and ocular hypertension (OHT).

If you are interested, please select the appropriate study to proceed.

Note: SSP studies are only available to patients who meet the selected criteria, and live within roughly a one hour range of existing clinical sites.